544529 (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 40 listed scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment securities. | |||||||||||||||
BSE revises price bands for 40 listed scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment securities.
| |||||||||||||||
BSE revises price bands for 40 scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment stocks. | |||||||||||||||
BSE revises price bands for 40 scrips effective March 9, 2026, with bands ranging from 1% to 20% across equity segment stocks.
| |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective March 09, 2026, including new additions, stage … | |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective March 09, 2026, including new additions, stage movements, and securities exiting the framework.
| |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, … | |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, 2026.
| |||||||||||||||